Abstract: A method, system, and recording medium for managing official accounts is disclosed. An official account management method includes the steps of setting a relation between official accounts that are accounts of sponsors on a messenger, and managing the official accounts by classifying the official accounts in a related account group in accordance with the relation between the official accounts.

Abstract: A method, system, and recording medium for managing official accounts is disclosed. An official account management method includes the steps of setting a relation between official accounts that are accounts of sponsors on a messenger, and managing the official accounts by classifying the official accounts in a related account group in accordance with the relation between the official accounts.

Abstract: The present invention relates to a novel heteroaryl compound, an enantiomer, a diastereomer or a pharmaceutically acceptable salt thereof, and an antiviral composition comprising the same as an active ingredient. The novel compounds represented by formula (I) or formula (II) according to the present invention are remarkably superior in antiviral activity against an influenza virus, and furthermore, have low cytotoxicity and thus low adverse effects on a human body. Therefore, a pharmaceutical composition containing the same as an active ingredient can be effectively used for the prevention or treatment of diseases caused by an influenza virus infection.

Abstract: In one example embodiment, a communication method includes identifying a selection instruction for content provided by a content provider, and establishing a communication link between a first account of a user and a second account of a business operator relevant to the content based on the identification of the selection instruction.

Abstract: The present invention relates to a novel heteroaryl compound, an enantiomer, a diastereomer or a pharmaceutically acceptable salt thereof, and an antiviral composition comprising the same as an active ingredient. The novel compounds represented by formula (I) or formula (II) according to the present invention are remarkably superior in antiviral activity against an influenza virus, and furthermore, have low cytotoxicity and thus low adverse effects on a human body. Therefore, a pharmaceutical composition containing the same as an active ingredient can be effectively used for the prevention or treatment of diseases caused by an influenza virus infection.

Abstract: In one example embodiment, a communication method includes identifying a selection instruction for content provided by a content provider, and establishing a communication link between a first account of a user and a second account of a business operator relevant to the content based on the identification of the selection instruction.

Abstract: In one example embodiment, a communication method includes identifying a selection instruction for content provided by a content provider, and establishing a communication link between a first account of a user and a second account of a business operator relevant to the content based on the identification of the selection instruction.

Abstract: A method, system, and recording medium for managing official accounts is disclosed. An official account management method includes the steps of setting a relation between official accounts that are accounts of sponsors on a messenger, and managing the official accounts by classifying the official accounts in a related account group in accordance with the relation between the official accounts.

Abstract: In one example embodiment, a communication method includes identifying a selection instruction for content provided by a content provider, and establishing a communication link between a first account of a user and a second account of a business operator relevant to the content based on the identification of the selection instruction.